1. Introduction {#sec0005}
===============

Multiple methods exist for differentiating human embryonic stem cells (hESC; derived from blastocysts) or induced pluripotent stem cells (hiPSC; derived from human subjects) *in vitro* to produce neurons ([@r19]; [@r25]; Schultz et al., 2003; [@r37]; [@r40]). Specific individual neuronal cell types such as mDA neurons([@r14]; [@r22]; [@r29]; [@r36]; [@r38]), and structures resembling the cerebral cortex ([@r2]; [@r9]; [@r10]; [@r28]) can also be produced from hPSCs. Although various types of neurons can be separately produced *in vitro*, there is no available method for allowing two separately-differentiated types of neurons to form connections with each other.

Recently, a technique which allows more complex structures, i.e. "organoids", to be produced *in vitro* as models of the brain per se, including various types of neurons, has been described ([@r15]). This technique allows multiple types of neurons to form; however, since brain regionalization in these organoids is inconsistent, there are difficulties in using this model to examine specific neuronal pathways, or for quantitative studies that would be required for examining developmental toxicity or for pharmacological applications. At present, there are no well-established methods for modeling interconnections between brain regions, or between neurons of different types, using hPSCs. Furthermore, there is currently no method which allows for the production of two separate types of neurons or cells from hPSCs and subsequently allowing them to interact.

For the brain, as compared to most other organs, e.g. the liver, there are major limitations involved in examining a single neuronal cell type in isolation. Brain developmental and functional processes are highly dependent on interactions between different neural cell types and between different regions of the brain (for example, [@r1]; [@r20]). A great deal of attention has, for example, been focused on differentiation of human mDA neurons from hPSCs ([@r14]; [@r22]; [@r29]; [@r36]; [@r38]) because of their potential for use in transplantation therapy for Parkinson's disease. The development and formation of mDA neurons does not, however, occur in isolation, and DA systems and their targets structures are highly interdependent (Halliday et al., 2000; [@r5]; [@r6]; [@r21]; [@r23]; [@r27]). Dopaminergic neurons are important for substance abuse ([@r34]; [@r36]), for motivational processes in general ([@r35]), and in the pharmacotherapy of schizophrenia ([@r13]; Weinberger and Lipska, 1995). Both schizophrenia and substance abuse are believed to involve interactions between mDA neurons and target cells in the forebrain ([@r13]; [@r11]; [@r31]). Therefore, the possibilities for employing either mDA neurons or neocortical neurons derived from hPSCs in isolation to elucidate substance abuse or schizophrenia are very limited. The availability of an hPSC-based model which would allow for the examination of mDA-cortical interactions would substantially enhance such studies.

The purpose of the present proposal is to develop a system which allows multiple brain structures or neuronal subtypes to be produced, that is, differentiated, from a single population of hPSCs, and subsequently allowed to interact. This system was applied to the mDA projection to the neocortex, but also has the potential to be used for any two structures that can be differentiated from hPSCs.

2. Methods {#sec0010}
==========

2.1. hPSC culture {#sec0015}
-----------------

hESC lines ES04 (P65--69), provided by ES Cell International (Singapore), and CT2 (P88--90), provided by University of Connecticut Stem Cell Core, were propagated in feeder-dependent culture, using irradiated mouse embryonic fibroblasts (MEF, Global Stem). hESCs were cultured in hESC medium, containing DMEM/F12 with 20% Knockout Serum Replacement (KSR), 2 mM L-Glutamine, *Pen/Strep* (50 *U/ml* and *μ*g/*ml*, *respectively*), 2 mM nonessential amino acids, 0.1 mM *β*-mercaptoethanol, and 4 ng/ml bFGF (all from Invitrogen). Colonies were passaged using 1 mg/ml Collagenase Type IV (Invitrogen) every 5 days (1:3 split ratio). Cell karyotype analyses were routinely performed on twenty G-banded metaphase cells.

2.2. Dopaminergic neuron differentiation {#sec0020}
----------------------------------------

hPSCs were differentiated to mDA neurons ([Fig. 1A](#rnn-33-3-rnn140488-g001){ref-type="fig"}) using an adaptation of the method described by Yan et al. (2005). Briefly, undifferentiated hPSC colonies (day 0) were grown as floating EBs in hESC medium without bFGF for 4 days. On day 4 the floating EBs were transferred to neural media containing DMEM/F-12 (2:1) with N2 supplement, 0.1 mM non-essential amino acids, 2*μ*g/ml heparin, supplemented with 20 ng/ml bFGF (Invitrogen) from days 4--6, and were then grown in adherent culture in same media from days 6--10. On day 10, bFGF was replaced with 50 ng/ml FGF8 (R&D), and the cells were maintained in this medium until day 16. On day 16, neural rosettes were isolated by manual dissection and grown as floating NE aggregates in neural medium supplemented with 50 ng/ml FGF8 for 2 days, followed by addition of 50 ng/ml FGF8 and 200 ng/ml SHH (R&D) from days 18--24. On day 24, NE aggregates were seeded on poly-ornithine/laminin-coated inner compartments of ibidi chambers and maintained in neurobasal medium containing N2 supplement, 0.1 mM non-essential amino acids, 0.5 mM L-Glutamine, 2*μ*g/ml heparin, 1*μ*M cAMP, 1*μ*g/ml laminin, and 200*μ*M ascorbic acid and supplemented with FGF8 (50 ng/ml), SHH (200 ng/ml, R&D), BDNF (10 ng/ml, R&D), and GDNF (10 ng/ml, R&D) until removal of the barrier on day 31 of differentiation.

2.3. Neocortical neuron differentiation {#sec0025}
---------------------------------------

Neocortical differentiation was performed according to the protocol illustrated in [Fig. 1B](#rnn-33-3-rnn140488-g001){ref-type="fig"}, essentially as described by [@r10] except that cells were dissociated on day 19, and at that time the ROCK inhibitor Y-27632 was added to the cultures. In brief, hPSC colonies were grown in non-adherent conditions in hESC medium without bFGF for four days, allowing EB formation. The EBs were then transferred to neural media containing DMEM/F-12 (2:1) with N2 supplement, 0.1 mM non-essential amino acids, and 2*μ*g/ml heparin, supplemented with 20 ng/ml bFGF for two additional days (day 6). Colonies were then grown in adherent culture, on laminin-coated plates, in the same media with 20 ng/ml bFGF from days 6 to 16. On day 16 dorsal cortical rosettes were isolated by manual dissection, dissociated into 50--100*μ*m diameter colonies, and maintained in suspended culture in the same medium with 20 ng/ml bFGF before being seeded on poly-ornithine/laminin coated dishes at day 19. On day 19, colonies were dissociated using accutase for 20 minutes at 37°C, washed using neural media, and placed into the outer area of the ibidi chambers in neurobasal medium containing B27 supplement, 0.1 mM non-essential amino acids, 0.5 mM L-Glutamine, and 2*μ*g/ml heparin but with the addition of FGF18 (20 ng/mL, Biosource), NT3 (20 ng/mL, R&D), BDNF (20 ng/mL, R&D) and the ROCK inhibitor Y-27632 (10*μ*M, Stemgent) until the barrier was removed on day 26 of differentiation.

2.4. Connection formation {#sec0030}
-------------------------

Connections between the mDA and neocortically-differentiated components were accomplished usingthe ibidi wound healing dish (ibidi GmbH, Planegg, Germany) (<http://ibidi.com/xtproducts/en/ibidi-Labware/Open-Slides-Dishes:-Removable-Chambers/Culture-Insert-Family>). Of various possible vessels that might be used for this technique, the ibidi dishes provide the best alternative that we have examined. These dishes are optimized for studies of wound healing, using dissociated keratinocytes or fibroblasts. The day at which the barrier between the inner and outer chambers was removed was day 31 for mDA differentiation, and day 26 for neocortical differentiation, as indicated in [Fig. 1A--C](#rnn-33-3-rnn140488-g001){ref-type="fig"}. On the day of barrier removal, the medium was changed and replaced with neurobasal medium containing B27 supplement, 0.1 mM non-essential amino acids, 0.5 mM L-Glutamine, and 2*μ*g/ml heparin, containing 20 ng/ml BDNF, and no other trophic factors.

2.5. Immunocytochemistry {#sec0035}
------------------------

Cells were fixed with 4% PFA for 10 min, washed with PBS, and blocked with 0.2% Triton X in PBS supplemented with 5% BSA and 10% goat/donkey serum. Cells were then incubated with primary antibodies in 0.2% Triton X in PBS with 5% BSA and 5% goat/donkey serum: rabbit anti-LMX1A (1:2,000, Millipore), goat anti-FOXA2 (1:50; Santa Cruz), rabbit anti-TH (1:500; Pel-Freez), mouse anti-TUJ1 (1:2,000; Promega), rabbit anti-TUJ1 (1:2,000; Covance), rabbit anti-OTX2 (1:1000; Millipore), mouse anti-Nestin (1:50; R&D), rabbit anti-BF1 (1:100; Abcam), mouse anti- NKX2.1 (1:200; Chemicon), rabbit anti-PAX6 (1:300; Covance), rabbit anti-Glutamate (1:2000; Sigma), rabbit anti-VGLUT1 (1:500; Synaptic Systems), rabbit anti-VGLUT2 (1:500; Synaptic Systems), mouse anti-GABA (1:100, Sigma), and rabbit anti-VGAT (1:500; Synaptic Systems).

Corresponding fluorescent-labeled secondary antibodies were used (Alexa-Fluor 488 for green, Alexa-Fluor 555 for red; R&D). Images were captured using a Carl Zeiss Axiovert 200M (Jena, Germany) microscope.

2.6. AAV viral transduction {#sec0040}
---------------------------

The construction of pdsAAVGFP has been described previously ([@r30]). Vectors were packaged based on the triple transfection method ([@r32]) as previously described ([@r7]). To provide the rep/cap genes for producing serotypes 2 and 6, pXX2 ([@r32]) and pAAV2/6 ([@r24]) were used respectively. Both AAV2 and AAV6 were purified by CsCl ultracentrifugation and titered using real-time PCR as previously described ([@r7]). A multiplicity of infection of 10,000 to 20,000 was used for transduction. The transduction efficiency was more than 80% as assessed by microscopic observation.

3. Results {#sec0045}
==========

3.1. mDA differentiation {#sec0050}
------------------------

For differentiation of mDA cells from hPSCs as illustrated in [Fig. 1A](#rnn-33-3-rnn140488-g001){ref-type="fig"}, colonies of mDA progenitor cells at day 31 expressed the mDA transcription factors LMX1A and FOXA2 ([Fig. 2A](#rnn-33-3-rnn140488-g002){ref-type="fig"}). When allowed to differentiate for 52 days ([Fig. 1A](#rnn-33-3-rnn140488-g001){ref-type="fig"}), in neurobasal medium with B27 supplement including BDNF as the only added trophic factor from days 31--52, the coloniescontained numerous TH^ +^ and TUJ1^ +^ neurons ([Fig. 2B, C](#rnn-33-3-rnn140488-g002){ref-type="fig"}). The colonies remained largely intact, with clusters of TH^ +^ fiber projections present at day 52 ([Fig. 2B](#rnn-33-3-rnn140488-g002){ref-type="fig"}). At day 52, TH^ +^ neurons comprised approximately one third of the total TUJ1 + cells ([Fig. 2C](#rnn-33-3-rnn140488-g002){ref-type="fig"}).

3.2. Neocortical differentiation {#sec0055}
--------------------------------

For differentiation of neocortical neurons from hPSCs, as illustrated in [Fig. 1B](#rnn-33-3-rnn140488-g001){ref-type="fig"} Nestin^ +^ neuroepithelial rosettes expressed the anterior telencephalic transcription factors OTX2 and BF1 ([@r16]), and the dorsal forebrain marker PAX6 ([@r17]), but did not express the ventral telencephalic marker NKX2.1 ([Fig. 3A](#rnn-33-3-rnn140488-g003){ref-type="fig"}). At the end of differentiation, on day 47 for neocortical differentiation, the majority of TUJ1^ +^ neurons had adopted a glutamatergic phenotype ([Fig. 3B](#rnn-33-3-rnn140488-g003){ref-type="fig"}), expressing the vesicular glutamate transporters VGLUT1 and VGLUT2 ([Fig. 3C](#rnn-33-3-rnn140488-g003){ref-type="fig"}). On day 47 the differentiated population also included a small population of GABA-containing neurons ([Fig. 3D](#rnn-33-3-rnn140488-g003){ref-type="fig"}) expressing VGAT ([Fig. 3E](#rnn-33-3-rnn140488-g003){ref-type="fig"}).

3.3. Connection formation {#sec0060}
-------------------------

To build connections between mDA and neocortical neurons as described in [Fig. 1C, D](#rnn-33-3-rnn140488-g001){ref-type="fig"}, the general distribution of progenitors within the inner and outer chambers is illustrated by the cartoon [Fig. 4A](#rnn-33-3-rnn140488-g004){ref-type="fig"}. The appearance of the gap between the inner and outer chambers is shown in [Fig. 4B](#rnn-33-3-rnn140488-g004){ref-type="fig"}. After the progenitors were seeded into ibidi chambers on day 24 of mDA differentiation and day 19 of neocortical differentiation, each type of progenitors was further differentiated using mDA-specific and neocortex-specific trophic factors for 1 week. After the barrier was removed, neuronal differentiation was continued for an additional 3 weeks using the same culture conditions for both neuronal subtypes, neurobasal medium with B27 supplement containing 20 ng/mL BDNF, but with no other trophic factors. At the end of differentiation, neurons retained their phenotypic identity and largely remained in their respective locations on each side of the barrier with few cells having migrated across the gap between the chambers, to the other side ([Fig. 4C--E](#rnn-33-3-rnn140488-g004){ref-type="fig"}). As can be seen in [Fig. 4C](#rnn-33-3-rnn140488-g004){ref-type="fig"} the gap between the two different neuronal populations narrowed over time, and some cells had moved into the area vacated by thebarrier.

Neocortical progenitors were infected using both AAV2- and AAV6-eGFP for 6 days, and ∼80% of neocortical neurons were positive for GFP at the end of differentiation ([Fig. 1C](#rnn-33-3-rnn140488-g001){ref-type="fig"}, D; [Fig. 4D, E](#rnn-33-3-rnn140488-g004){ref-type="fig"}). Immuno\\-staining and fluorescence imaging showed that a few GFP^ +^ neocortical cells had migrated into the area of mDAergic TH^ +^ neurons, while conversely a few TH^ +^ cells were seen in the area of the outer chamber, among the GFP^ +^ neocortical neurons. Nonetheless, the majority of cells remained in the areas of the inner and outer chambers respectively. In areas where groups of TH^ +^ neurons were in proximity to GFP^ +^ neocortical neurons, TH^ +^ projections were seen to have extended outward from the DA neurons, crossing the gap and extending into the area of neocortical neurons ([Fig. 4D](#rnn-33-3-rnn140488-g004){ref-type="fig"}). In some cases the TH^ +^ neurons had elaborated processes which had the appearance of terminal arborization ([Fig. 4E](#rnn-33-3-rnn140488-g004){ref-type="fig"}, lower left), resembling that which is seen in DA target areas of the rat brain (e.g., [@r18]).

4. Discussion {#sec0065}
=============

We have succeeded in arranging differentiation, plating, and trophic factor conditions which allow mDA and neocortical neurons to be differentiated from hPSCs and form connections *in vitro*. Although many previous methods allow hPSCs to be induced to differentiate into multiple types of neurons, it has not been possible to produce two different kinds of neurons in the same culture vessel, because within one culture vessel different trophic factors cannot be separately applied to each neuronal progenitor population. If neuronal progenitors of different types are terminally differentiated in separate vessels, the differentiated neurons are not amenable to removal and transfer from one vessel to a separate location to allow the neurons to interact. There are various types of culture vessels which allow trophic factors to be applied to different sub-groups of cells, such as chamber slides, or "sticky" inserts, but these methods are not useful in the present situation for various reasons, such as a wide gap between the cell populations or the complications involved in transferring an entire chamber slide to a larger vessel. If, however, the two separate cell types are differentiated using the ibidi wound-healing dish, the interaction problem can be solved by removal of the cell barrier at an appropriate stage.

Many types of studies related to disorders including drug abuse, schizophrenia, Parkinson's disease, and perhaps eating disorders, attention deficit-hyperactivity disorder, Tourette's syndrome, and Lesch-Nyhan syndrome, which may involve dopaminergic systems ([@r8]) could be enhanced through this use of this model, as compared to the use of mDA neurons in isolation. For example, hPSC-derived mDA neurons have been used as a model of MPP+ toxicity and GDNF protection ([@r39]), but MPP+ toxicity is known to involve the fine terminal arborization of mDA terminals in thestriatum, which occur only in the presence of appropriate synaptic targets of mDA neurons as well (Feuerstetin et al., 1988), and thus such studies might be enhanced. Co-cultures of mDA neurons and striatal neurons for use in studies of MPP+ toxicity can be created from rodent fetal material ([@r12]), but this allows for similar studies using human material.

Among various available types of culture vessels and materials that might be adapted for this purpose, the ibidi wound-healing dish is the best alternative that we have found. Notwithstanding the favorable propertiesof this type of dish, we believe that the principal limitation is the small size of the surface available for these cultures. Thus, when mDA progenitor colonies are placed into the wells, they do not distribute uniformly, and the size of the chambers is too small to allow for consistent sampling. Since the mDA progenitors used in this study do not form projections well if entirely dissociated, the cells cannot be smoothly distributed within the small area available using the present technique. There are various other geometries of this kind of dish which might be envisioned to further improve the outcome, or to facilitate quantification. Nonetheless, even with the available geometry of the ibidi dishes, the present technique allows two different types of neurons to be separately induced from hPSCs, and subsequently allowed to interact. This method, therefore, has the potential to expand the potential of hPSC-derived neurons to allow for studies of human neural systems and interconnections that have previously not been possible to model *in vitro*.
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![Illustration of the differentiation and connection protocol. (A) Protocol for induction of the mesencephalic dopaminergic component, adapted from the method described by Yan et al. (2005). The upper line indicates days of differentiation, beginning with day 0, the final day at which hPSCs were maintained in undifferentiated growth conditions. Abbreviations in red (defined in the boxed insert) below the upper line indicate differentiation stages. The lower line indicates the trophic factors (blue) which were added at each stage. (B) Protocol for induction of neocortical differentiation, based on the method of Kindberg et al. (2014). Abbreviations in green indicate differentiation stages and the trophic factors added are indicated in blue below the lower line. (C and D) Stages of the neuronal subtype interconnection model; numbers in italics below C correspond to the stages illustrated in D. 1: Progenitors are differentiated in separate plates. 2: Progenitors are seeded into separate compartments of ibidi dishes. 3: Infection by AAV-eGFP; or other manipulations of each separate cell type can be performed while the cell types remain in separate compartments, treated with different combinations of trophic factors. 4: The barrier between cell types is removed. 5: Neuronal differentiation is allowed to continue for 3 weeks, with both cells types exposed to the same media containing BDNF only.](rnn-33-3-rnn140488-g001){#rnn-33-3-rnn140488-g001}

![Dopaminergic differentiation. (A) Expression of LMX1A and FOXA2, transcription factors for mesencephalic DA progenitor cells, at day 31, prior to removal of the barrier between cell types. Scale bar = 50*μ*m. (B) Expression of TH (red) and TUJ1 (green) by immunocytochemistry at day 52, for mDA neurons differentiated according to the protocol, as shown in [Fig. 1A](#rnn-33-3-rnn140488-g001){ref-type="fig"}, showing projections extending from colonies positive for TH and TUJ1. Scale bar = 100*μ*m. (C) Higher magnification image of mDA neurons differentiated for 52 days showing individual TH-positive (red) and TUJ1-positive (green) neurons. Scale bar = 50*μ*m. Cell line: ES04.](rnn-33-3-rnn140488-g002){#rnn-33-3-rnn140488-g002}

![Neocortical differentiation. (A) Characterization of neocortical neuroepithelial rosettes derived from hPSCs on day 16 of differentiation. Nestin^ +^ rosettes (green) contain cells expressing the anterior telencephalic transcription factors OTX2 (red, left frame), BF1 (red, middle frame), and PAX6 (green, right frame). In contrast, the ventral telencephalic marker NKK2.1 (red, right frame) was not expressed. Nuclei are stained with DAPI (blue). Scale bar = 50*μ*m. (B) Immunocytochemical staining for glutamate (red) and TUJ1 (green) on day 47 of differentiation using the current protocol, as shown in [Fig. 1B](#rnn-33-3-rnn140488-g001){ref-type="fig"}. Scale bar = 25*μ*m. (C) TUJ1^ +^ neurons (green) were positive for the vesicular glutamate transporters VGLUT1 (red, left frame) and VGLUT2 (red, right frame) on day 47 of differentiation. Nuclei are stained with DAPI (blue). Scale bar = 50*μ*m. (D) Expression of GABA (red) and TUJ1 (green) by immunocytochemistry on day 47 of differentiation. Scale bar = 100*μ*m. (E) Expression of the GABA transporter VGAT (red) and TUJ1 (green) by immunocytochemistry on day 47 of differentiation. Scale bar = 25*μ*m. Cell line: ES04.](rnn-33-3-rnn140488-g003){#rnn-33-3-rnn140488-g003}

![Development of projections between neocortical and DA neurons. (A) Illustration of the process of progenitor seeding into separate chambers, and development of connections after removal of the barrier between chambers. (B) Illustration of the gap between chambers after removal of the barrier (courtesy of ibidi GmbH, Planegg, Germany). Phase contrast image, scale bar = 500*μ*m. (C) Phase contrast images of the gap between the inner and outer chambers on day 1 after removal of the barrier and after 21 days. Note that the gap between DA and neocortical neurons persists on day 21 although some cells and projections are seen between the two regions. Scale bar = 100*μ*m. (D) An example of TH-positive projections (red) from the inner chamber to the area of the outer chamber after 21 days. Scale bar = 100*μ*m. (E) An example of TH-positive projection forming a fine terminal aborization among GFP^ +^ neocortical cells, seen in the lower left of the merged image. Scale bar = 100*μ*m. Neocortical neurons were labelled with AAV-eGFP (green). Note that some eGFP-positive cells have migrated across the gap, to the inner area, and are interspersed with TH-positive neurons. These cells appear yellow in these images. Cell line: CT2.](rnn-33-3-rnn140488-g004){#rnn-33-3-rnn140488-g004}
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